Gram-Positive Antibiotic Selection and Dosing
For Gram-positive infections, your antibiotic choice depends primarily on the organism identified and its resistance pattern: use penicillin or ceftriaxone for susceptible streptococci, oxacillin/nafcillin or cefazolin for methicillin-susceptible staphylococci (MSSA), and vancomycin for methicillin-resistant staphylococci (MRSA).
Streptococcal Infections
Highly Penicillin-Susceptible Streptococci (MIC ≤0.1 μg/mL)
This includes most viridans streptococci and groups A, B, C, G streptococci 1:
First-line options:
- Penicillin G: 200,000-300,000 U/kg/day IV divided every 4 hours (max 12-24 million U daily)
- Ceftriaxone: 100 mg/kg/day IV divided every 12 hours OR 80 mg/kg/day IV once daily (max 4 g daily)
Alternatives for penicillin allergy:
- Vancomycin: 40 mg/kg/day IV divided every 8-12 hours (max 2 g daily) 1
- First-generation cephalosporin (cefazolin): 100 mg/kg/day IV divided every 8 hours (max 12 g daily) 1
Relatively Resistant Streptococci (MIC ≥0.2 μg/mL)
This includes enterococci and less-susceptible viridans streptococci 1:
Recommended regimen:
- Penicillin G (200,000-300,000 U/kg/day IV divided every 4 hours) OR Ampicillin (200-300 mg/kg/day IV divided every 4-6 hours, max 12 g daily)
- PLUS Gentamicin: 3-6 mg/kg/day IV divided every 8 hours (adults: 3-5 mg/kg/day) for first 2 weeks, or entire course for enterococci 1
For aminoglycoside-resistant enterococci:
- Ampicillin plus ceftriaxone: Ampicillin 200-300 mg/kg/day IV divided every 4-6 hours PLUS ceftriaxone 100 mg/kg/day IV divided every 12 hours 1
Alternative for penicillin allergy:
- Vancomycin: 40 mg/kg/day IV divided every 8-12 hours (max 2 g daily) plus gentamicin 1
Staphylococcal Infections
Methicillin-Susceptible Staphylococcus aureus (MSSA)
Parenteral first-line:
- Oxacillin or nafcillin: 200 mg/kg/day IV divided every 4-6 hours (max 12 g/day) 1
- Cefazolin: 100 mg/kg/day IV divided every 8 hours (max 12 g daily) 1, 2
Recent data suggest cefazolin may be as effective as oxacillin/nafcillin with fewer adverse events 2. Cefazolin is appropriate for penicillin-allergic patients except those with immediate hypersensitivity reactions 3.
Oral options:
- Dicloxacillin: 500 mg four times daily (pediatric: 25 mg/kg/day in 4 divided doses) 3
- Cephalexin: 500 mg four times daily (pediatric: 25 mg/kg/day in 4 divided doses) 3
For penicillin allergy:
- Vancomycin: 40 mg/kg/day IV divided every 8-12 hours (max 2 g daily) for severe β-lactam allergy 1
- Clindamycin: 600 mg IV every 8 hours OR 300-450 mg PO three times daily (pediatric: 25-40 mg/kg/day IV in 3 divided doses or 10-20 mg/kg/day PO in 3 divided doses) 3, 4
Methicillin-Resistant Staphylococcus aureus (MRSA)
Parenteral first-line:
- Vancomycin: 40 mg/kg/day IV divided every 8-12 hours (max 2 g daily) 1
Alternative parenteral options:
- Daptomycin: 6 mg/kg IV every 24 hours (pediatric <6 years: 10 mg/kg) 1
- Linezolid: 600 mg IV/PO every 12 hours (pediatric: 10 mg/kg every 8 hours, max 600 mg/dose) 2, 3, 4
Oral options for less severe infections:
- Clindamycin: 300-450 mg three times daily (pediatric: 10-20 mg/kg/day in 3 divided doses) 3, 4
- Caution: potential for inducible resistance in erythromycin-resistant strains 3
- TMP-SMX: 1-2 double-strength tablets twice daily (pediatric: 8-12 mg/kg/day based on trimethoprim component) 3, 4
- Doxycycline: 100 mg twice daily (not for children <8 years) 3, 4
- Linezolid: 600 mg twice daily (pediatric: 10 mg/kg every 8 hours) 3, 4
Vancomycin-Resistant or Intolerant Staphylococci
- Daptomycin: 6 mg/kg IV every 24 hours (pediatric <6 years: 10 mg/kg) 1
Special Considerations for Prosthetic Material
For all staphylococcal infections with prosthetic material present: Add rifampin (15-20 mg/kg/day divided every 12 hours, max 600 mg) PLUS gentamicin (3-6 mg/kg/day IV divided every 8 hours) for the first 2 weeks 1
The benefit of adjunctive rifampin and gentamicin remains unclear, with gentamicin carrying more risk of harm 2.
Skin and Soft Tissue Infections
Simple Abscesses
Incision and drainage alone is likely adequate for simple abscesses or boils 4. Antibiotics are recommended when there are systemic signs, extensive disease, or failure to respond to drainage alone.
Purulent Cellulitis (CA-MRSA suspected)
Follow MRSA oral regimens above 4.
Nonpurulent Cellulitis
Empirical therapy should cover β-hemolytic streptococci 4:
- β-lactam (cephalexin or dicloxacillin): 500 mg four times daily 4
Add MRSA coverage if the patient fails β-lactam therapy or has systemic toxicity 4.
Necrotizing Infections
Broad empirical coverage is essential as these can be polymicrobial or monomicrobial 5:
- Vancomycin or linezolid PLUS piperacillin-tazobactam OR carbapenem OR ceftriaxone plus metronidazole 5
For documented group A streptococcal necrotizing fasciitis:
- Penicillin plus clindamycin 5
Common Pitfalls
Vancomycin dosing: Pediatric serious infections require higher doses (60 mg/kg/day divided every 6 hours) compared to less severe infections (40 mg/kg/day) 1
Clindamycin resistance: Be aware of inducible resistance in erythromycin-resistant MRSA strains 3
Cefazolin for MSSA: Despite theoretical concerns about inoculum effect, recent observational data support its use with lower adverse event rates than oxacillin/nafcillin 2
Daptomycin dosing: The FDA-approved dose is 6 mg/kg/day, but many experts use 8-10 mg/kg/day for serious infections to prevent treatment failure 2
TMP-SMX limitations: Pregnancy category C/D; not recommended in third trimester or children <2 months 4
Aminoglycoside monitoring: Dose based on lean body mass and monitor levels for individualization 6